HomeBUSINESS
BUSINESS

Parmodia, Canalia Climb GP Recollection Ranking in August: Anterio
(Oct.25.2017)

Kowa Pharmaceutical’s hoped-to-be big-seller hyperlipidemia med Parmodia (pemafibrate) and Mitsubishi Tanabe Pharma’s diabetes combo Canalia (teneligliptin + canagliflozin) left strong impressions on GPs in August through a series of promotional channels, including drug reps, a monthly survey showed ...
(LOG IN FOR FULL STORY)

News Calendar